Long-Term Efficacy and Safety of Infliximab plus Methotrexate for The Treatment of Polyarticular Course Juvenile Rheumatoid Arthritis: Findings from an Open-Label Treatment Extension (vol 69, pg 585, 2010)

被引:0
|
作者
Ruperto, Nicolino
Lovell, Daniel J.
Cuttica, Ruben
机构
关键词
D O I
10.1136/ard.2008.100354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1106 / 1106
页数:1
相关论文
共 50 条
  • [41] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
    Opoka-Winiarska, Violetta
    Zuber, Zbigniew
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Nikishina, Irina
    Debowska, Grazyna
    Smolewska, Elzbieta
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816
  • [42] PERSISTENCE OF TOFACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES UP TO 7 YEARS
    Pope, J.
    Keystone, E.
    Jamal, S.
    Wang, L.
    Fallon, L.
    Woolcott, J.
    Lazariciu, I.
    Haraoui, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 245 - 245
  • [43] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years
    Pope, Janet E.
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Chapman, Douglass
    Haraoui, Boulos
    [J]. ACR OPEN RHEUMATOLOGY, 2019, 1 (02) : 73 - 82
  • [44] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8 Years
    Pope, Janet
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Haraoui, Boulos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [46] Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis:: Safety and efficacy in an open-label clinical trial
    Antoni, CE
    Nüsslein, HG
    Wollenhaupt, J
    Burmester, GR
    Krüger, K
    Kalden, JR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 276 - 276
  • [47] Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial
    Kalden, J. R.
    Nuesslein, H. G.
    Wollenhaupt, J.
    Burmester, G. -R.
    Krueger, K.
    Antoni, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : 834 - 840
  • [48] Analysis of Integrated Radiographic Data From Two Long-Term, Open-Label Extension Studies of Adalimumab for the Treatment of Rheumatoid Arthritis
    Landewe, Robert
    Ostergaard, Mikkel
    Keystone, Edward C.
    Florentinus, Stefan
    Liu, Shufang
    van der Heijde, Desiree
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (02) : 180 - 186
  • [49] TOFACITINIB, AN ORAL JAK INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND CLINICAL AND RADIOGRAPHIC EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES OVER 7 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Terry, K. K.
    Kwok, K.
    Lazariciu, I.
    Nduaka, C.
    Connell, C. A.
    DeMasi, R.
    Wang, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 252 - 252
  • [50] Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
    Brunner, Hermine I.
    Ruperto, Nicolino
    Zuber, Zbigniew
    Cuttica, Ruben
    Keltsev, Vladimir
    Xavier, Ricardo M.
    Burgos-Vargas, Ruben
    Penades, Inmaculada Calvo
    Silverman, Earl D.
    Espada, Graciela
    Zavaler, Manuel Ferrandiz
    Kimura, Yukiko
    Duarte, Carolina
    Job-Deslandre, Chantal
    Joos, Rik
    Douglass, Wendy
    Wimalasundera, Sunethra
    Bharucha, Kamal N.
    Wells, Chris
    Lovell, Daniel J.
    Martini, Alberto
    de Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 530 - 541